SPHK1 and cancer: There is a strong causal association between adverse, or overactive, SphK/S1P signaling and cancer, and there are extensive recent reviews on the importance of maintaining the balance of the SphK-S1P rheostat in the prevention and/or development of cancer [11,12,13,14,15,16,17,18].